Talquetamab-related dysgeusia in multiple myeloma compared to BCMA-targeted bispecifics and high-dose melphalan - Fleischer, Anna; Roll, Magdalena; Frenking, Jan; Panther, Franziska; Gelbrich, Götz; Strunz, Patrick-Pascal; Riedhammer, Christine; Peter, Jessica; Mersi, Julia; Waldschmidt, Johannes; Kortüm, Martin; Einsele, Hermann; et al. (Cancer medicine, 2025)
Zuerst veröffentlicht: 08. Dezember 2025